Tevogen Pursues Generics Expansion with Apozeal Acquisition Bid
Tevogen Bio ($TVGN) targets Apozeal Pharmaceutical acquisition to gain 11 FDA-approved generics and strengthen domestic drug manufacturing.
TVGNTVGNWsupply chain resilienceLetter of Intent